Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

RiDYMO® has been successfully employed in various drug discovery programs, including the development of small molecule ...

LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a ...

Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and ...

Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

While challenges remain, AI is accelerating the process by enabling researchers to identify and design new drug candidates ...

In a strategic move to expand its footprint in the healthcare sector, Advanced Micro Devices (AMD) has announced a $20 ...

The company has successfully developed small molecule drugs that directly target viral proteins essential to the polyomavirus life cycle. Polyomaviruses lack conventional antiviral protein targets ...

In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting ...